2-237371833-C-T

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BA1

The NM_004369.4(COL6A3):​c.4184G>A​(p.Arg1395Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00365 in 1,613,540 control chromosomes in the GnomAD database, including 170 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R1395W) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0044 ( 13 hom., cov: 32)
Exomes 𝑓: 0.0036 ( 157 hom. )

Consequence

COL6A3
NM_004369.4 missense

Scores

2
15

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:10

Conservation

PhyloP100: 0.596

Publications

19 publications found
Variant links:
Genes affected
COL6A3 (HGNC:2213): (collagen type VI alpha 3 chain) This gene encodes the alpha-3 chain, one of the three alpha chains of type VI collagen, a beaded filament collagen found in most connective tissues. The alpha-3 chain of type VI collagen is much larger than the alpha-1 and -2 chains. This difference in size is largely due to an increase in the number of subdomains, similar to von Willebrand Factor type A domains, that are found in the amino terminal globular domain of all the alpha chains. These domains have been shown to bind extracellular matrix proteins, an interaction that explains the importance of this collagen in organizing matrix components. Mutations in the type VI collagen genes are associated with Bethlem myopathy, a rare autosomal dominant proximal myopathy with early childhood onset. Mutations in this gene are also a cause of Ullrich congenital muscular dystrophy, also referred to as Ullrich scleroatonic muscular dystrophy, an autosomal recessive congenital myopathy that is more severe than Bethlem myopathy. Multiple transcript variants have been identified, but the full-length nature of only some of these variants has been described. [provided by RefSeq, Jun 2009]
COL6A3 Gene-Disease associations (from GenCC):
  • Bethlem myopathy 1A
    Inheritance: AD, AR, SD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Ambry Genetics
  • collagen 6-related myopathy
    Inheritance: AD, AR Classification: DEFINITIVE Submitted by: ClinGen
  • Ullrich congenital muscular dystrophy 1C
    Inheritance: AR Classification: DEFINITIVE Submitted by: G2P
  • dystonia 27
    Inheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED, NO_KNOWN Submitted by: Illumina, Labcorp Genetics (formerly Invitae), ClinGen, Ambry Genetics, Orphanet
  • Ullrich congenital muscular dystrophy 1A
    Inheritance: AR, AD, SD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Genomics England PanelApp
  • Bethlem myopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Ullrich congenital muscular dystrophy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0020683706).
BP6
Variant 2-237371833-C-T is Benign according to our data. Variant chr2-237371833-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 94929.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.0716 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_004369.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
COL6A3
NM_004369.4
MANE Select
c.4184G>Ap.Arg1395Gln
missense
Exon 9 of 44NP_004360.2
COL6A3
NM_057167.4
c.3566G>Ap.Arg1189Gln
missense
Exon 8 of 43NP_476508.2
COL6A3
NM_057166.5
c.2363G>Ap.Arg788Gln
missense
Exon 6 of 41NP_476507.3

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
COL6A3
ENST00000295550.9
TSL:1 MANE Select
c.4184G>Ap.Arg1395Gln
missense
Exon 9 of 44ENSP00000295550.4
COL6A3
ENST00000472056.5
TSL:1
c.2363G>Ap.Arg788Gln
missense
Exon 6 of 41ENSP00000418285.1
COL6A3
ENST00000392004.7
TSL:1
c.3566G>Ap.Arg1189Gln
missense
Exon 8 of 8ENSP00000375861.3

Frequencies

GnomAD3 genomes
AF:
0.00442
AC:
672
AN:
151966
Hom.:
13
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000628
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00813
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.0783
Gnomad SAS
AF:
0.00418
Gnomad FIN
AF:
0.00519
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000588
Gnomad OTH
AF:
0.00192
GnomAD2 exomes
AF:
0.0100
AC:
2511
AN:
251046
AF XY:
0.00890
show subpopulations
Gnomad AFR exome
AF:
0.000615
Gnomad AMR exome
AF:
0.0242
Gnomad ASJ exome
AF:
0.000198
Gnomad EAS exome
AF:
0.0730
Gnomad FIN exome
AF:
0.00549
Gnomad NFE exome
AF:
0.000748
Gnomad OTH exome
AF:
0.00619
GnomAD4 exome
AF:
0.00358
AC:
5227
AN:
1461456
Hom.:
157
Cov.:
31
AF XY:
0.00347
AC XY:
2523
AN XY:
726996
show subpopulations
African (AFR)
AF:
0.000358
AC:
12
AN:
33480
American (AMR)
AF:
0.0223
AC:
998
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.000153
AC:
4
AN:
26136
East Asian (EAS)
AF:
0.0757
AC:
3007
AN:
39700
South Asian (SAS)
AF:
0.00241
AC:
208
AN:
86258
European-Finnish (FIN)
AF:
0.00713
AC:
378
AN:
52990
Middle Eastern (MID)
AF:
0.00156
AC:
9
AN:
5768
European-Non Finnish (NFE)
AF:
0.000325
AC:
361
AN:
1112006
Other (OTH)
AF:
0.00414
AC:
250
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
336
671
1007
1342
1678
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
70
140
210
280
350
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00439
AC:
668
AN:
152084
Hom.:
13
Cov.:
32
AF XY:
0.00491
AC XY:
365
AN XY:
74312
show subpopulations
African (AFR)
AF:
0.000626
AC:
26
AN:
41508
American (AMR)
AF:
0.00805
AC:
123
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.0779
AC:
400
AN:
5132
South Asian (SAS)
AF:
0.00418
AC:
20
AN:
4784
European-Finnish (FIN)
AF:
0.00519
AC:
55
AN:
10604
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000588
AC:
40
AN:
67994
Other (OTH)
AF:
0.00190
AC:
4
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
29
58
87
116
145
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00380
Hom.:
39
Bravo
AF:
0.00548
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.000581
AC:
5
ExAC
AF:
0.00920
AC:
1117
Asia WGS
AF:
0.0270
AC:
94
AN:
3478
EpiCase
AF:
0.000545
EpiControl
AF:
0.000296

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:10
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Benign:5
Dec 19, 2013
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Mar 31, 2020
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Jun 23, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.

Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed.

not provided Benign:2
Nov 03, 2016
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Dystonia 27 Uncertain:1
Oct 22, 2022
Department of Neurology, Xijing Hospital, Fourth Military Medical University
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Ullrich congenital muscular dystrophy 1A;C4225336:Dystonia 27;CN029274:Bethlem myopathy 1A Benign:1
Aug 20, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Bethlem myopathy 1A Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Collagen 6-related myopathy Benign:1
Mar 06, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.084
BayesDel_addAF
Benign
-0.41
T
BayesDel_noAF
Benign
-0.30
CADD
Benign
18
DANN
Uncertain
0.99
DEOGEN2
Benign
0.15
T
Eigen
Benign
-0.33
Eigen_PC
Benign
-0.20
FATHMM_MKL
Benign
0.58
D
LIST_S2
Uncertain
0.89
D
MetaRNN
Benign
0.0021
T
MetaSVM
Benign
-0.86
T
MutationAssessor
Benign
0.46
N
PhyloP100
0.60
PrimateAI
Benign
0.27
T
PROVEAN
Benign
-0.57
N
REVEL
Benign
0.26
Sift
Benign
0.36
T
Sift4G
Benign
0.67
T
Polyphen
0.93
P
Vest4
0.21
MVP
0.84
MPC
0.49
ClinPred
0.017
T
GERP RS
4.8
PromoterAI
-0.097
Neutral
Varity_R
0.080
gMVP
0.33
Mutation Taster
=97/3
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs80272723; hg19: chr2-238280476; COSMIC: COSV55083723; API